Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Roche Holding ROP 1.21%increase; up pointing triangle said a drug candidate showed better potential than existing therapies in…
Roche Backs Full-Year View as First-Half Sales Rise
Roche Holding ROP 0.00%increase; up pointing triangle backed its full-year guidance as its pharmaceuticals division helped drive a…
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Novartis NOVN -0.02%decrease; down pointing triangle said it agreed to pay up to $1.5 billion for Myricx Bio,…
UBS trading head Barron to lead investment bank AI strategy
Skip to main content Investment Banking The Swiss bank is upping its use of AI across its investment…
Roche Bets Splits in Obesity Market Will Open Door to New Entrants
Roche Holding expects the obesity market to split into segments as weight-loss drugs reach the wider public, opening…
Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study
Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its…
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Novartis NOVN -1.20%decrease; red down pointing triangle said it agreed to buy biotech company Excellergy for up to…
Exclusive | Anthropic Adds Novartis CEO to Board
Anthropic has appointed Vas Narasimhan, chief executive of Swiss pharmaceutical company Novartis NOVN 0.56%increase; green up pointing triangle,…
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Novartis NOVN 1.69%increase; green up pointing triangle said it agreed to buy biotech company Excellergy for up to…
Human rights compliance and Pakistan’s GSP+ in focus at Geneva UNHRC event
Geneva [Switzerland], March 14 (ANI): A side event during the 61st Session of the United Nations Human Rights…